Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Total Non-Current Liabilities: 2018

Historic Total Non-Current Liabilities for Cidara Therapeutics (CDTX) over the last 1 years, with Dec 2018 value amounting to $19.6 million.

  • Cidara Therapeutics' Total Non-Current Liabilities was N/A to $19.8 million in Q1 2019 from the same period last year, while for Mar 2019 it was $19.8 million, marking a year-over-year change of. This contributed to the annual value of $19.6 million for FY2018, which is N/A change from last year.
  • Cidara Therapeutics' Total Non-Current Liabilities amounted to $19.6 million in FY2018.
  • Cidara Therapeutics' Total Non-Current Liabilities' 5-year high stood at $19.6 million during FY2018, with a 5-year trough of $19.6 million in FY2018.
  • Its 1-year average for Total Non-Current Liabilities is $19.6 million, with a median of $19.6 million in 2018.